What is LOPJLB’s current signal on BRVE?

LOPJLB’s latest quantitative signal on Braveheart Bio, Inc. (BRVE) is SELL. Signals are updated daily.

What market regime is BRVE in?

LOPJLB classifies each ticker into Bull, Recovery, Ranging, Bear, or Crisis regimes using a Hidden Markov Model.

What does Braveheart Bio, Inc. (BRVE) do?

Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor. The company was founded on May 13,2024 and is headquartered in San Francisco, CA.

Where is Braveheart Bio, Inc. based / listed?

Braveheart Bio, Inc. is based in US, listed on NASDAQ.

Braveheart Bio, Inc. (BRVE)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$21.35+0.38%Close

SELL

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $1.5B
Beta: 0.00
Shares short: 2.5M

Days to cover: 7.5
SI change: +76.2%

1W: +1.33%
1M: -18.73%

vs SPY 1W: +0.12%
vs SPY 1M: -19.19%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Prediction markets

Company news